Euromonitor International
- Item successfully added to cart!
  
  Your cart is empty
  
  Check Out View Cart

Country Report

Analgesics in

Analgesics in Japan

21 pages, Feb 2019

US$990

Add to cart Pay by invoice

New Report Guarantee

If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extract FREE!

Executive Summary

New Report Guarantee

If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extract FREE!

PROSPECTS

Active promotion supports the growth of adult combination products

In 2018, adult combination products continued to show strong growth, supported by the performance of well-known brands and their active promotion. Arax’s Norshin brand continued to see active promotion in 2018, with renewed airing of television commercials.

Adult aspirin declines, as consumers seek alternative treatments

Adult aspirin continued to decline in current value terms in 2018, due to consumers avoiding unnecessary medication and opting for alternative treatments. Although headaches and migraines continue to trouble consumers, they are more informed and educated about other remedies to try before taking medication, thanks to having more access to information through the internet.

Topical analgesics/anaesthetic expected to surge

As the 2020 Tokyo Olympics and Paralympics approach, the environment in Japan has shifted towards encouraging sports, with the whole nation showing more interest in daily workouts and sports in general. This is spread throughout the generations, including the elderly.

COMPETITIVE LANDSCAPE

Hisamitsu Pharmaceutical leads analgesics

Hisamitsu Pharmaceutical continued to lead analgesics in 2018, with a strong presence in topical analgesics/anaesthetic, supported by highly recognised brands such as Salonpas and Faitas. Salonpas is well-known for its popularity amongst inbound tourists visiting Japan.

Sanofi’s presence rises after the acquisition of SSP

Sanofi expanded its presence in analgesics after acquiring SSP in 2017, which continued to lead systemic analgesics in 2018. SSP’s Eve brand supported the growth of the company.

Awareness is set to be boosted by sponsorship

In February 2018, Hisamitsu Pharmaceutical announced that it will become one of the official partners for the 2020 Tokyo Olympics and Paralympics. It is expected that this sponsorship will further help raise awareness of its brands both locally and globally.

Files are delivered directly into your account within a few minutes of purchase.

Samples

Analgesics Market Sample Report Analgesics Market Sample Data

Overview

Why buy this report?

Gain competitive intelligence about market leaders. Track key industry trends, opportunities and threats. Inform your marketing, brand, strategy and market development, sales and supply functions.

Samples (FAQs about samples):

Delivery: Files are delivered directly into your account within a few minutes of purchase.

Overview

Discover the latest market trends and uncover sources of future market growth for the Analgesics industry in Japan with research from Euromonitor's team of in-country analysts.

Find hidden opportunities in the most current research data available, understand competitive threats with our detailed market analysis, and plan your corporate strategy with our expert qualitative analysis and growth projections.

If you're in the Analgesics industry in Japan, our research will save you time and money while empowering you to make informed, profitable decisions.

The Analgesics in Japan market research report includes:

Analysis of key supply-side and demand trends
Detailed segmentation of international and local products
Historic volumes and values, company and brand market shares
Five year forecasts of market trends and market growth
Robust and transparent market research methodology, conducted in-country

Our market research reports answer questions such as:

What is the market size of Analgesics in Japan?
What are the major brands in Japan?
Are combination products with acetaminophen still popular?

Why buy this report?

Gain competitive intelligence about market leaders
Track key industry trends, opportunities and threats
Inform your marketing, brand, strategy and market development, sales and supply functions

This industry report originates from Passport, our Consumer Health market research database.

Want to find out more about this report?

Request more information

Analgesics in Japan - Category analysis

HEADLINES

PROSPECTS

Active promotion supports the growth of adult combination products

Adult aspirin declines, as consumers seek alternative treatments

Topical analgesics/anaesthetic expected to surge

COMPETITIVE LANDSCAPE

Hisamitsu Pharmaceutical leads analgesics

Sanofi’s presence rises after the acquisition of SSP

Awareness is set to be boosted by sponsorship

CATEGORY DATA

Table 1 Sales of Analgesics by Category: Value 2013-2018
Table 2 Sales of Analgesics by Category: % Value Growth 2013-2018
Table 3 Sales of Topical Analgesics/Anaesthetic by Format: % Value 2013-2018
Table 4 NBO Company Shares of Analgesics: % Value 2014-2018
Table 5 LBN Brand Shares of Analgesics: % Value 2015-2018
Table 6 Forecast Sales of Analgesics by Category: Value 2018-2023
Table 7 Forecast Sales of Analgesics by Category: % Value Growth 2018-2023

Consumer Health in Japan - Industry Overview

EXECUTIVE SUMMARY

The healthy living mindset spreads, leading to growth in sports nutrition

Disappointing impact of the new tax system on OTC products

Players offering switched OTC products enjoy growth

Internet retailing rises, whilst drugstores/parapharmacies continues to lead

Continued growth is expected, as consumers’ health concerns rise

MARKET INDICATORS

Table 8 Consumer Expenditure on Health Goods and Medical Services: Value 2013-2018
Table 9 Life Expectancy at Birth 2013-2018

MARKET DATA

Table 10 Sales of Consumer Health by Category: Value 2013-2018
Table 11 Sales of Consumer Health by Category: % Value Growth 2013-2018
Table 12 NBO Company Shares of Consumer Health: % Value 2014-2018
Table 13 LBN Brand Shares of Consumer Health: % Value 2015-2018
Table 14 Penetration of Private Label in Consumer Health by Category: % Value 2013-2018
Table 15 Distribution of Consumer Health by Format: % Value 2013-2018
Table 16 Distribution of Consumer Health by Format and Category: % Value 2018
Table 17 Forecast Sales of Consumer Health by Category: Value 2018-2023
Table 18 Forecast Sales of Consumer Health by Category: % Value Growth 2018-2023

Megatrends

Country Report

Analgesics in Japan

New Report Guarantee

Executive Summary

New Report Guarantee

PROSPECTS

Active promotion supports the growth of adult combination products

Adult aspirin declines, as consumers seek alternative treatments

Topical analgesics/anaesthetic expected to surge

COMPETITIVE LANDSCAPE

Hisamitsu Pharmaceutical leads analgesics

Sanofi’s presence rises after the acquisition of SSP

Awareness is set to be boosted by sponsorship

Samples

Overview

Why buy this report?

Samples (FAQs about samples):

Want to find out more about this report?

Table of Contents

Analgesics in Japan - Category analysis

HEADLINES

PROSPECTS

Active promotion supports the growth of adult combination products

Adult aspirin declines, as consumers seek alternative treatments

Topical analgesics/anaesthetic expected to surge

COMPETITIVE LANDSCAPE

Hisamitsu Pharmaceutical leads analgesics

Sanofi’s presence rises after the acquisition of SSP

Awareness is set to be boosted by sponsorship

CATEGORY DATA

Consumer Health in Japan - Industry Overview

EXECUTIVE SUMMARY

The healthy living mindset spreads, leading to growth in sports nutrition

Disappointing impact of the new tax system on OTC products

Players offering switched OTC products enjoy growth

Internet retailing rises, whilst drugstores/parapharmacies continues to lead

Continued growth is expected, as consumers’ health concerns rise

MARKET INDICATORS

MARKET DATA

APPENDIX

OTC registration and classification

Vitamins and dietary supplements registration and classification

Self-medication/self-care and preventive medicine

Switches

SOURCES

Why buy this report?

Want to find out more about this report?

Recently Viewed

Complete Catalogue

Country Reports

Strategy Reports

Recently Viewed

Complete Catalogue

Country Reports

Strategy Reports